Keyphrases
Leishmania Donovani
100%
Visceral Leishmaniasis
81%
Trypanosoma Brucei
70%
Drug Target
62%
Drug Discovery
61%
Trypanosoma Cruzi (T. cruzi)
50%
Nitroreductase
45%
Leishmania
44%
Trypanothione
43%
Antitrypanosomal Activity
43%
T. Brucei
40%
Nitro
35%
Molecular Targets
35%
Human African Trypanosomiasis
34%
Fexinidazole
34%
Trypanosomatids
33%
Mode of Action
33%
Antileishmanial Activity
32%
Leishmania Major
28%
Antileishmanial
28%
Leishmania Infantum
27%
Nifurtimox
26%
Mechanism of Action
24%
Chagas Disease
23%
EC50
23%
African Trypanosomes
22%
Anti-trypanosomatid Drugs
22%
Plasmodium Falciparum
20%
Thermal Proteome Profiling
20%
Hit Compound
19%
Metabolism
19%
Antikinetoplastids
18%
Trypanothione Synthetase
18%
Antimonials
18%
Preclinical Candidate
18%
Amastigote
17%
Phenotypic Screening
16%
Sb(III)
16%
Glyoxalase
16%
Pyridine
16%
Glutathione
16%
Trypanosome
16%
Promastigote
16%
Malaria
15%
Mouse Model
15%
Pharmacophore
15%
Drug Candidates
14%
Antimony
14%
IC50
14%
Brucei
14%
Pharmacology, Toxicology and Pharmaceutical Science
Visceral Leishmaniasis
74%
Drug Discovery
66%
Trypanothione
49%
Trypanosoma Brucei
46%
Leishmania donovani
45%
Nitroreductase
45%
Leishmania
44%
Trypanosomatidae
38%
Antitrypanosomal
37%
African Trypanosomiasis
37%
Trypanosoma
37%
Fexinidazole
35%
Amastigote
32%
Chagas Disease
31%
Diseases
30%
Trypanosoma Cruzi
29%
Structure Activity Relationship
26%
EC50
23%
Nifurtimox
22%
Antimonial
22%
Pharmacokinetics
22%
Glutathione
22%
Synthetase
21%
Leishmania Major
20%
Cyclin Dependent Kinase
18%
Mouse Model
18%
Molecular Target
18%
Peroxidase
16%
Drug Resistance
15%
IC50
15%
Antimalarial Agent
14%
Lead Compound
14%
Protozoon
14%
Thiol
14%
Nitroquinoline Derivative
13%
Pyridine Derivative
13%
Cytotoxicity
13%
Proteasome
13%
Promastigote
12%
Tropical Disease
12%
Kinetoplastida
11%
Leishmaniasis
11%
Transferase
11%
Naphthyridine Derivative
11%
Lactoperoxidase
11%
Comet Assay
11%
Adenosine Triphosphate
10%
Cleavage and Polyadenylation Specificity Factor
10%
Clinical Trial
10%
Benznidazole
10%